Hide Board Information

Show Board Information

RenovoRx Inc. RNXT

Board Mod: Add me as mod

Asst Mods:

Last Post: 12/21/2023 10:03:02 AM

Board Marks: 1

Posts Today: 0

Board Views Today: 3

RenovoRx Inc. (NASDAQ: RNXT) Stock Message Board

1. RNXT Company Profile

    

2. RNXT Time & Sales

    

3. RNXT Recent News

    

4. RNXT Filings

    

5. RNXT Financials

    

6. RNXT Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

8	$RNXT RenovoRx Engages Oklahoma University (OU)	louied91	12/21/2023 10:03:02 AM
7	$RNXT RenovoRx Announces Clinical Data Abstract	louied91	12/19/2023 9:32:27 AM
6	RenovoRx Announces Clinical Data Abstract at the	Lee Adams	12/19/2023 9:04:23 AM
5	$RNXT RenovoRx Files New International Patent for	louied91	12/13/2023 10:31:12 AM
4	RenovoRx Files New International Patent for Novel	Lee Adams	12/13/2023 9:44:44 AM
3	RenovoRx Expands Scientific Advisory Board with	Lee Adams	12/12/2023 11:49:59 AM
2	RenovoRx Reports Third Quarter 2023 Financial	Lee Adams	12/12/2023 11:47:40 AM
1	RNXT - Swing Cycle	J L	11/10/2021 12:41:27 PM

Recent Articles

• Alibaba's Bold Move into AI and Real Estate Fuels Stock Surge
• Leidos and VML Launch Cutting-Edge AI Platform for Defense
• Valitor Welcomes Gregory Kunst as New CEO to Lead Growth
• The Remarkable Growth of Tesla: A 15-Year Investment Journey
• New Terms Announced in XOMA Royalty and LAVA Agreement
• DeLeion Capital Introduces a Trustworthy Custody Option for XRP
• Davis Commodities Plans Major ESG Agri-Trade Growth Ahead
• Lawsuit Filed Against Baxter International Over Device Issues
• Ramsay Santé's 2025 Annual Results: Continued Growth Amid Challenges
• Oracle's Ambitious Growth Plan Sparks Mixed Reactions
• Apple's Exclusive Formula 1 Deal is a Game Changer for Fans
• Understanding Market Trends for Applied Optoelectronics Inc
• Understanding the Rise in Short Interest for TSM
• Analyzing KKR Real Estate Finance Trust Inc's Short Interest Trends
• Protalix BioTherapeutics Faces Market Challenges and Reactions
• Your Rights as Shareholders: Investigating Corporate Actions
• Astromania Casino Begins Global Operations with Innovative Platform
• Landmark Bancorp, Inc. Gears Up for Q3 Earnings Discussion
• Key Updates for Lantheus Holdings Investors Amid Legal Actions
• Kevin Hern's Accenture Stock Sale: A Closer Look
• Exploring the 14th International Smartphone Film Festival
• Globee Awards Invites Startups to Showcase Their Successes Now
• The Impressive Growth of Blackstone Stock Over the Years
• Industrial Micro Filter Market Trends Shaping the Future
• Insider Stock Options Exercised by Fastenal's Michael Ancius
• Celebrating the Marine Corps with New Henry Rifles Models
• Robert J Ben's Strategic Move: Exercising Options for Growth
• Emerging Trends and Future of Phase Change Memory Market
• CEO Randall K Fields Sells $108K in ReposiTrak Shares
• Insider Selling Activity at Emergent BioSolutions Raises Questions
• Boston Scientific Expands Portfolio with Nalu Medical Acquisition
• The Growth Journey of an Investment in Marsh & McLennan
• Alibaba's AI and Cloud Investments Drive Significant Growth
• Fresnillo PLC: Seizing the Spotlight Amid Gold's Surge
• In-Depth Semiconductor Market Comparison: NVIDIA vs Peers
• Comparative Analysis of Microsoft in the Software Sector
• Meta Platforms: A Deep Dive Into Competitive Positioning
• Analyzing Amazon's Competitive Position in Retail Sector
• Understanding TKO Group Holdings: A Deep Dive into P/E Metrics
• Apple's Competitive Edge in Technology Hardware Market
• Insights Into Caterpillar's Recent Options Market Activity
• Understanding Recent Trends in ASML Holding Options Activity
• Exploring the Growth of Security Printing Services Through 2034
• Investors Eye META with Unusual Options Activity Trends
• Robotics Revolutionizing Drug Discovery with AI Integration
• Bank of America Raises Stake in TCM Group's Share Capital
• RLI Corp's Earnings Preview: Insights for Investors
• Anticipating Zions Bancorp's Upcoming Earnings Report
• Van Herk Investments Acquires Major Stake in Zealand Pharma
• Dynex Capital's Anticipated Earnings Report: What to Expect